Khutsoane, D <br/><br/>
Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.  [electronic resource] 

 -  Diabetes, obesity & metabolism  Mar 2008 
 - 212-22 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/j.1463-1326.2007.00826.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biphasic Insulins<br/>Blood Glucose--metabolism<br/>Diabetes Mellitus, Type 2--blood<br/>Family Practice<br/>Humans<br/>Hypoglycemia--metabolism<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--analogs & derivatives<br/>Insulin Aspart<br/>Insulin, Isophane<br/>Treatment Outcome